| Vol. 9.27 – 21 July, 2021 |
| |
|
|
| Scientists described a human monoclonal antibody, designated S2X259, recognizing a highly conserved cryptic receptor-binding domain epitope and cross-reacting with spikes from all sarbecovirus clades. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| To enhance antigen processing and cross-presentation in draining lymph nodes, researchers developed an interferon-armed receptor-binding domain dimerized by an immunoglobulin fragment. [Cell Research] |
|
|
|
| The authors expanded SARS-CoV-2 T cells from the peripheral blood of COVID-19-recovered donors and non-exposed controls using different culture conditions. [Cell Reports] |
|
|
|
| Scientists analyzed whether B.1.617 is more adept in entering cells and/or evades antibody responses. B.1.617 entered two of eight cell lines tested with roughly 50% increased efficiency and was equally inhibited by two entry inhibitors. [Cell Reports] |
|
|
|
| Researchers described that in addition to dendritic cell (DC) deficiency, several DC activation and homing markers were altered in acute COVID-19 patients, which were associated with multiple inflammatory markers. [Cellular & Molecular Immunology] |
|
|
|
| Investigators utilized RenMab, a novel mouse carrying the entire human antibody variable region, for neutralizing antibody discovery. [Cell Discovery] |
|
|
|
| Scientists investigated the antiviral effects of a Salvia miltiorrhiza compound, Danshensu, in vitro and in vivo, including the mechanism of S protein-mediated virus attachment and entry into target cells. [Acta Pharmacologica Sinica] |
|
|
|
| The authors demonstrated subcutaneous (SC) prime and SC boost vaccination of CD-1 mice with a dual-antigen vaccine elicits T-helper cell 1 biased T-cell and humoral responses to both spike (S) and nucleocapsid that were greater than those seen with human adenovirus serotype 5 S wild type delivering only unmodified S. [Scientific Reports] |
| MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
|
|
|
| Researchers demonstrated that CX3CR1+ effector cells bore a striking similarity to short-lived effector cells during acute infection. [Nature Immunology] |
|
|
|
| Investigators demonstrated that serine phosphorylation of the N-terminal domain at positions 14, 17 and 18 suppressed myxovirus resistance 2 (MX2) antiviral function, prevented interactions with the HIV-1 capsid and nuclear transport factors, and was reversed by myosin light chain phosphatase. [Nature Microbiology] |
|
|
|
| Scientists demonstrated that membrane-associated RING-CH 8, E3 ubiquitin protein ligase (MARCH8) profoundly inhibited influenza A virus replication both in vitro and in mice. [Nature Communications] |
|
|
|
| Researchers revealed that similar to the GI mucosae, oral CD4+ T cells were rapidly depleted, and as one of the first comprehensive analyses of the oral microflora in SIV infection, they also observed significant modulation among two genera, Porphyromonas and Actinobacillus, early after infection. [Scientific Reports] |
|
|
|
|
| The rapid and remarkably successful development, manufacture, and deployment of several effective SARS-CoV-2 vaccines is now tempered by three key challenges. [Cell Host & Microbe] |
|
|
|
|
| Roche announced that Japan’s Ministry of Health, Labour and Welfare has approved Ronapreve™, for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. [Roche (GlobeNewswire, Inc.)] |
|
|
|
| Enzo Biochem, Inc. announced that it has received an expansion of its FDA Emergency Use Authorization for the company’s rapid extraction method on its proprietary test system for the detection of coronavirus SARS-CoV-2 including the genetic variants that are now proliferating globally. [Enzo Biochem, Inc. (GlobeNewswire, Inc.)] |
|
|
|
|
| September 13 – 15, 2021 Virtual |
|
|
|
|
|
| Tübingen University – Tuebingen, Germany |
|
|
|
| University of Basel – Basel, Switzerland |
|
|
|
| Johns Hopkins University – Baltimore, Maryland, United States |
|
|
|
| Hummingbird Bioscience – Singapore, Singapore |
|
|
|
| The European Molecular Biology Laboratory – Barcelona, Spain |
|
|
|
|